Peptide CK3 (CLKADKAKC) as described by Feng et al. (Feng et al., 2014) showed higher ability binding to MDA-MB-231 breast tumor cells than other breast tumor cells such as 4T-1, MCF-7 and MDA-MB-435 breast tumor cells (Figure 2). This evidence concerns the gene KRT3 and breast neoplasm.